Evidence map›Paper›PMID 32154456›Full record

ArticleKidney international reports2020

Red Blood Cell AE1/Band 3 Transports in Dominant Distal Renal Tubular Acidosis Patients.

Jean-Philippe Bertocchio, Sandrine Genetet, Lydie Da Costa, Stephen B Walsh, Bertrand Knebelmann, Julie Galimand, Lucie Bessenay, Corinne Guitton, Renaud De Lafaille, Rosa Vargas-Poussou and 2 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. eLife · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Evaluation of the efficacy ofFrontiers in pharmacology · 2023
    Article
  9. Article
  10. Review
  11. Familial distal renal tubular acidosis.The Journal of international medical research · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Jean-Philippe BertocchioRenal and Metabolic Diseases Unit, Assistance Publique-Hôpitaux de Paris, European Georges Pompidou Hospital, Paris, France.
Sandrine GenetetUMR_S1134, Integrated Red Globule Biology (IRGB), Inserm, University of Paris, Paris, France.
Lydie Da CostaUMR_S1134, Integrated Red Globule Biology (IRGB), Inserm, University of Paris, Paris, France.
Stephen B WalshDepartment of Renal Medicine, University College of London, London, UK.
Bertrand KnebelmannNephrology Department, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades Hospital, Paris, France.
Julie GalimandService d'Hématologie Biologique, Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Paris, France.
Lucie BessenayPediatrics Department, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.
Corinne GuittonPediatrics Department, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Renaud De LafailleNephrology Department, University Hospital of Bordeaux, Bordeaux, Aquitaine, France.
Rosa Vargas-PoussouReference Center for Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.
Dominique EladariRenal and Metabolic Diseases Department, CHU de la Réunion, Felix Guyon Hospital, Saint Denis, France.
Isabelle Mouro-ChanteloupUMR_S1134, Integrated Red Globule Biology (IRGB), Inserm, University of Paris, Paris, France.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRDélégation Paris 5 · FRHôpital Necker-Enfants Malades · FRUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnion exchanger 1 (AE1) (

methodsWe retrospectively collected clinical and biological data from patients harboring dRTA due to a

resultsFifteen patients were included. All experience nephrolithiasis and/or nephrocalcinosis, 2 had SAO and dRTA (dRTA SAO+), 13 dominant dRTA (dRTA SAO-). The latter did not exert specific RBC membrane anomalies. Both HCO

conclusionBand 3 transport function and expression in RBCs from dRTA SAO- patients is normal. However, in SAO RBCs, impaired conformation of AE1/band 3 corresponds to an impaired function. Thus, the driver of acid-base defect during dominant dRTA is probably an impaired membrane expression.

Indexed as

acidosis, renal tubularanion exchange protein 1erythrocytehematologic diseasesnephrocalcinosisnephrolithiasis

Identifiers

PMID32154456
PMCPMC7056926
OpenAlexW2999468293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.